IL152461A0 - Directly compressed solid dosage articles - Google Patents

Directly compressed solid dosage articles

Info

Publication number
IL152461A0
IL152461A0 IL15246101A IL15246101A IL152461A0 IL 152461 A0 IL152461 A0 IL 152461A0 IL 15246101 A IL15246101 A IL 15246101A IL 15246101 A IL15246101 A IL 15246101A IL 152461 A0 IL152461 A0 IL 152461A0
Authority
IL
Israel
Prior art keywords
solid dosage
directly compressed
compressed solid
copolymer
active ingredient
Prior art date
Application number
IL15246101A
Other languages
English (en)
Original Assignee
Noveon Ip Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noveon Ip Holdings Corp filed Critical Noveon Ip Holdings Corp
Publication of IL152461A0 publication Critical patent/IL152461A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
IL15246101A 2000-04-27 2001-04-17 Directly compressed solid dosage articles IL152461A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/559,687 US6623756B1 (en) 2000-04-27 2000-04-27 Directly compressed solid dosage articles
PCT/US2001/012400 WO2001082894A2 (en) 2000-04-27 2001-04-17 Directly compressed solid dosage particles

Publications (1)

Publication Number Publication Date
IL152461A0 true IL152461A0 (en) 2003-05-29

Family

ID=24234605

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15246101A IL152461A0 (en) 2000-04-27 2001-04-17 Directly compressed solid dosage articles
IL152461A IL152461A (en) 2000-04-27 2002-10-24 Directly compressed solid dosage articles

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152461A IL152461A (en) 2000-04-27 2002-10-24 Directly compressed solid dosage articles

Country Status (13)

Country Link
US (1) US6623756B1 (xx)
EP (1) EP1276466B1 (xx)
JP (1) JP2003531848A (xx)
CN (1) CN1195498C (xx)
AT (1) ATE255886T1 (xx)
BR (1) BR0110287A (xx)
CA (1) CA2407140A1 (xx)
DE (1) DE60101468T2 (xx)
ES (1) ES2211796T3 (xx)
IL (2) IL152461A0 (xx)
MX (1) MXPA02010437A (xx)
WO (1) WO2001082894A2 (xx)
ZA (1) ZA200208571B (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6623754B2 (en) 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20040185016A1 (en) * 2002-07-30 2004-09-23 Popp Karl F Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US7704522B2 (en) 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
FI20080346A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
FI20080355A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi metforminia käsittävien tablettien valmistamiseksi
FI20080353A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
CN101467988B (zh) * 2007-12-27 2014-07-09 北京德众万全医药科技有限公司 一种含有氨酚伪麻的药用组合物及其制备方法
US20110284573A1 (en) * 2008-12-17 2011-11-24 Allan Dagsland Method of providing a target dose, powder provider device and its use
AR077712A1 (es) 2009-08-05 2011-09-14 Idenix Pharmaceuticals Inc Inhibidores de serina proteasa macrociclica
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
MY159958A (en) 2009-12-18 2017-02-15 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
JP5933554B2 (ja) 2010-09-01 2016-06-15 アムビト ビオスシエンセス コルポラチオン 光学活性のあるピラゾリルアミノキナゾリン及びその医薬組成物及び使用方法
CN103270030B (zh) 2010-09-01 2016-01-20 埃姆比特生物科学公司 吡唑基氨基喹唑啉的氢溴酸盐
CA2819859A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
EP2670396A1 (en) 2011-01-31 2013-12-11 Celgene Corporation Pharmaceutical compositions of cytidine analogs and methods of use thereof
WO2012109398A1 (en) 2011-02-10 2012-08-16 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
US9365556B2 (en) 2012-03-16 2016-06-14 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
US20160229866A1 (en) 2013-09-20 2016-08-11 Idenix Pharmaceuticals Inc. Hepatitis c virus inhibitors
EP3114122A1 (en) 2014-03-05 2017-01-11 Idenix Pharmaceuticals LLC Solid forms of a flaviviridae virus inhibitor compound and salts thereof
CN106661027B (zh) 2014-03-20 2019-12-24 卡佩拉医疗公司 苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症
AU2015231202B9 (en) 2014-03-20 2019-10-24 Capella Therapeutics, Inc. Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
US9546163B2 (en) 2014-12-23 2017-01-17 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
JP2022520011A (ja) 2019-01-24 2022-03-28 ノヴォ ノルディスク アー／エス ローラコンパクタおよびローラコンパクタを使用する乾式造粒の方法
JP2022547094A (ja) 2019-09-06 2022-11-10 ノヴォ ノルディスク アー／エス 医薬組成物における使用のための顆粒の分別のための方法および機器

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
CH606154A5 (xx) * 1974-07-02 1978-11-15 Goodrich Co B F
US4267103A (en) * 1978-12-07 1981-05-12 The B. F. Goodrich Company Solvent polymerization of carboxyl containing monomers
DE3888520T2 (de) * 1988-03-30 1994-07-21 Japan Synthetic Rubber Co Ltd Hoch vernetzte Polymerteilchen und Verfahren zur Herstellung derselben.
WO1993023457A1 (en) * 1992-05-09 1993-11-25 Gel-Chem Limited Conversion of powdered polymers
US5288814A (en) * 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension

Also Published As

Publication number Publication date
US6623756B1 (en) 2003-09-23
MXPA02010437A (es) 2003-04-25
ATE255886T1 (de) 2003-12-15
JP2003531848A (ja) 2003-10-28
ES2211796T3 (es) 2004-07-16
BR0110287A (pt) 2003-02-18
CN1426297A (zh) 2003-06-25
IL152461A (en) 2007-08-19
DE60101468D1 (de) 2004-01-22
WO2001082894A3 (en) 2002-02-21
WO2001082894A2 (en) 2001-11-08
EP1276466A2 (en) 2003-01-22
EP1276466B1 (en) 2003-12-10
CN1195498C (zh) 2005-04-06
CA2407140A1 (en) 2001-11-08
ZA200208571B (en) 2003-08-19
DE60101468T2 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
IL152461A0 (en) Directly compressed solid dosage articles
EP2258345A3 (en) Solid pharmaceutical dosage form comprising an HIV protease inhibitor solid dispersion
CA2385890A1 (en) Controlled release compositions comprising nimesulide
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
CA2217462A1 (en) Controlled release biodegradable micro- and nanospheres containing cyclosporin
EP2165703A3 (en) Direct compression formulation and process
CA2231195A1 (en) Sustained release matrix for high-dose insoluble drugs
AU6517596A (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
NZ325844A (en) A bioadhesive tablet comprising a c16-c22alkyl fumarate as lubricant
EP1211951A4 (en) PROCESS FOR MANUFACTURING A PHARMACEUTICAL MACHINE GUM
BG102228A (en) Medicamentous form with controlled release of slightly soluble medicamentous substances
CA2534056A1 (en) Calcium carbonate granulation
WO2002089773A3 (en) Pharmaceutical compositions comprising cyclosporin
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
PT1195160E (pt) Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
GEP20033078B (en) Controlled-Release Compositions of Betahistine
CA2339193A1 (en) Pharmaceutical compositions comprising ibuprofen and domperidone
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
CA2454449C (en) Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
WO2002067854A3 (en) Manufacture of thyroid hormone tablets having consistent active moiety amounts

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: NOVEON, INC

Free format text: FORMER NAME:NOVEON IP HOLDINGS CORP.

FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: LUBRIZOL ADVANCED MATERIALS, INC.

Free format text: FORMER NAME:NOVEON, INC